Point of Care Technology Research Center in Primary Care - Blueprint Pilot

初级保健护理点技术研究中心 - 蓝图试点

• 批准号: 10390583
• 负责人: John A Parrish
• 金额: $ 48.92万
• 依托单位: MASSACHUSETTS GENERAL HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-07-01 至 2022-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10390583
• 关键词: Address; Area; Award; Caring; Chronic Disease; Clinical; Clinical Research; Collaborations; Elements; Emerging Technologies; Engineering; Environment; Funding; Goals; Hand; Health; Health Alliance; Health Technology; Healthcare; Hospitals; Institution; Interdisciplinary Study; International; Laboratories; Licensing; Medicine; Methodology; Military Medicine; Modeling; National Institute of Biomedical Imaging and Bioengineering; Outcome; Patients; Performance; Point of Care Technology; Primary Care Physician; Primary Health Care; Process; Recommendation; Research; Resources; Scientist; Singapore; Site; Speed; Students; Technology; Testing; Training; Translational Research; Translations; U-Series Cooperative Agreements; Universities; aging population; care providers; clinical application; commercialization; design; experience; follow-up; improved; industry partner; innovation; innovative technologies; meetings; point of care; prototype

Project Summary/Abstract: Overall The Point-of-Care Technology Research Center in Primary Care proposes to further develop a national “center-without-walls” for rapid transformation of emerging point-of-care technologies into commercially viable, clinically focused solutions for improving primary healthcare. The Center was established by the Consortia for Improving Medicine through Innovation and Technology (CIMIT), a consortium of research institutions, universities, military medicine centers and hospitals throughout the US with international affiliates at University of Manchester-UK (MIMIT), Barcelona (The Center for the Integration of Medicine and Innovative Technologies in Catalonia) and Singapore (A*-STAR/Eastern Health Alliance). CIMIT established the Point-of- Care Technology Research Center in Primary Care under a Cooperative Agreement (U54) award from National Institute of Biomedical Imaging and Bioengineering (NIBIB) in 2012 and the Center created a national network of research sites, harnessing the power of multidisciplinary collaboration to speed the translation of high-impact research into primary care practice and broader dissemination by commercially licensable opportunities. We will build upon our proven approach to needs-driven primary healthcare technology innovation to expand and significantly enhance our Center. The Center’s overall objective is to build upon the progress made under the previous U54 award and offer expanded support to teams through the integrated functional elements of the proposed enhanced Center. In so doing, the Center will offer a portfolio of synergistic support to teams with innovative solutions through defined interfaces and hand offs throughout the innovation process while continuously improving the Center’s processes of finding, funding, facilitating, and following projects. The long-term goal is to create a dynamic, sustainable national network that identifies key unmet needs in the delivery of primary care as well as promising emerging technologies and then to accelerate their translation into clinical applications for broad impact in primary care medicine through high-quality translational and clinical research.

项目概要/摘要：总体 初级保健中的即时技术研究中心建议进一步开发一种 国家“无墙中心”，用于快速转变新兴的护理点技术 转化为商业上可行的、以临床为重点的解决方案，以改善初级医疗保健。的 该中心是由通过创新改善医学联盟和 技术（CIMIT），研究机构，大学，军事医学中心的联盟 和遍布美国的医院，并在英国曼彻斯特大学设有国际分支机构 （MIMIT），巴塞罗那（医学和创新技术整合中心， 加泰罗尼亚）和新加坡（A*-星星/东部健康联盟）。CIMIT建立了 合作协议下的初级保健护理技术研究中心（U 54） 2012年获得国家生物医学成像和生物工程研究所（NIBIB）的奖项， 中心创建了一个全国性的研究网站网络，利用多学科的力量， 合作，以加快将高影响力的研究转化为初级保健实践， 通过商业许可证的机会更广泛地传播。我们将建立在我们的证明， 以需求为导向的初级保健技术创新方法，以扩大和显著 加强我们的中心。该中心的总体目标是，在联合国 之前的U 54奖项，并通过集成的功能为团队提供更广泛的支持， 拟议的强化中心的要素。在这样做的时候，该中心将提供一个组合， 通过定义的接口和移交，为团队提供协同支持，提供创新解决方案 在整个创新过程中，同时不断改进中心的流程， 寻找、资助、促进和跟踪项目。长期目标是创造一个充满活力， 可持续的国家网络，确定在提供初级保健方面未得到满足的主要需求， 以及有前途的新兴技术，然后加速将其转化为临床 通过高质量的翻译和翻译， 临床研究